May 19, 2016 Mark Leahey, CEO and President of MDMA, delivers his “State of the Industry” address on reimbursement, the medical device tax, UnitedHealthcare/Medtronic and a little bit...
May 15, 2016 A recent jury decision cleared Vascular Solutions of charges of improper off-label marketing. Former Acclarent CEO Bill Facteau discusses his indictment in a similar case,...
May 3, 2016 Abbott’s move to acquire St. Jude demonstrates how Medtronic’s moves toward “Total Solutions” may change the game in Medtech. We’re going to tackle that topic...
April 28, 2016 Though initially surprised by Medtronic’s move to buy Covidien, Stacy Enxing Seng says she immediately saw the wisdom of the deal and recognized the opportunity...
April 21, 2016 Thomas Gunderson watched the Medtech market for over 20 years at Piper Jaffray. Now recently retired, Gunderson explains how innovation in Medtech is changing, what...
April 14, 2016 Cynthia Yee, a principal at Windham Venture Partners, opened her firm’s office in San Francisco. Yee shares her opinions on many medtech questions including 510(k)...
April 7, 2016 The Medtech industry earns only passing grades in the category of product design, according to product development group Nottingham Spirk. But the company hopes to...
March 30, 2016 HealthQuest Capital secured a $225 million fund to invest in new health care technologies. Managing Director Garheng Kong, MD, explains the firm’s views on health...
March 23, 2016 Experienced medtech CEO Kerry Pope explains how the Fogarty Institute is building coalitions of corporations and entrepreneurs to create medtech start-ups.